It's time to kill the patient COVID-19 tax

It's time to kill the patient COVID-19 tax
Illustration Credit: Greg Groesch/Washington Times

More than 30 million Americans are now unemployed. These folks need all the help our nation can offer. Yet, disturbingly, the Trump administration just finalized a rule that will dramatically spike pharmacy costs. 

The rule allows insurers to disregard manufacturer coupons when calculating patients’ out-of-pocket expenses. This will increase what patients must spend before their insurance kicks in, potentially making critical prescriptions too expensive to fill.

For many Americans, high out-of-pocket costs already drive many to skip needed medicines.

 
Sign Up for Our Email Newsletter

RECENT NEWS

CMPI Interview: Drugmaker Eli Lilly Caps Insulin Cost
  • Newsmax TV
  • 03/02/2023 12:00 AM

CMPI Interview: Drugmaker Eli Lilly Caps Insulin Cost

Peter Pitts joins Newsmax TV to discuss Eli Lilly's cap on insulin cost...  Read more

New Report Demonstrates How Hospitals, Pharmacies & PBMs Exploit the Federal 340B Drug Program to the Harm of Disadvantaged Patients
  • CMPI
  • 09/09/2022 12:00 AM

New Report Demonstrates How Hospitals, Pharmacies & PBMs Exploit the Federal 340B Drug Program to the Harm of Disadvantaged Patients

Nation’s largest hospitals, pharmacy benefit managers (PBMs), and pharmacies abuse drug discount program to pocket saving...  Read more

Peter Pitts on CDC reorganization proposal

Peter Pitts on CDC reorganization proposal

Peter Pitts joins NEWSY to discuss proposed CDC changes...  Read more

DRUGWONKS BLOG